Bicycle Therapeutics Stock Forward View - Simple Regression
| BCYC Stock | USD 6.42 0.10 1.53% |
Bicycle Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast Bicycle Therapeutics stock prices and determine the direction of Bicycle Therapeutics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Bicycle Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
At the present time, the RSI of Bicycle Therapeutics' share price is approaching 44 suggesting that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Bicycle Therapeutics, making its price go up or down. Momentum 44
Sell Extended
Oversold | Overbought |
EPS Estimate Next Quarter (1.03) | EPS Estimate Current Year (3.87) | EPS Estimate Next Year (3.48) | Wall Street Target Price 21.5 | EPS Estimate Current Quarter (1.03) |
Using Bicycle Therapeutics hype-based prediction, you can estimate the value of Bicycle Therapeutics from the perspective of Bicycle Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Bicycle Therapeutics using Bicycle Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Bicycle using crowd psychology based on the activity and movement of Bicycle Therapeutics' stock price.
Bicycle Therapeutics Implied Volatility | 2.51 |
Bicycle Therapeutics' implied volatility exposes the market's sentiment of Bicycle Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Bicycle Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Bicycle Therapeutics stock will not fluctuate a lot when Bicycle Therapeutics' options are near their expiration.
The Simple Regression forecasted value of Bicycle Therapeutics on the next trading day is expected to be 6.85 with a mean absolute deviation of 0.29 and the sum of the absolute errors of 17.39. Bicycle Therapeutics after-hype prediction price | USD 6.52 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Bicycle Therapeutics to cross-verify your projections. Prediction based on Rule 16 of the current Bicycle contract
Based on the Rule 16, the options market is currently suggesting that Bicycle Therapeutics will have an average daily up or down price movement of about 0.16% per day over the life of the 2026-03-20 option contract. With Bicycle Therapeutics trading at USD 6.42, that is roughly USD 0.0101 . If you think that the market is fully incorporating Bicycle Therapeutics' daily price movement you should consider acquiring Bicycle Therapeutics options at the current volatility level of 2.51%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Open Interest Against 2026-03-20 Bicycle Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Bicycle Therapeutics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Bicycle Therapeutics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Bicycle Therapeutics stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Bicycle Therapeutics' open interest, investors have to compare it to Bicycle Therapeutics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Bicycle Therapeutics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Bicycle. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Bicycle Therapeutics Additional Predictive Modules
Most predictive techniques to examine Bicycle price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Bicycle using various technical indicators. When you analyze Bicycle charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Bicycle Therapeutics Simple Regression Price Forecast For the 31st of January
Given 90 days horizon, the Simple Regression forecasted value of Bicycle Therapeutics on the next trading day is expected to be 6.85 with a mean absolute deviation of 0.29, mean absolute percentage error of 0.12, and the sum of the absolute errors of 17.39.Please note that although there have been many attempts to predict Bicycle Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Bicycle Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Bicycle Therapeutics Stock Forecast Pattern
| Backtest Bicycle Therapeutics | Bicycle Therapeutics Price Prediction | Buy or Sell Advice |
Bicycle Therapeutics Forecasted Value
In the context of forecasting Bicycle Therapeutics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Bicycle Therapeutics' downside and upside margins for the forecasting period are 3.37 and 10.33, respectively. We have considered Bicycle Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Regression forecasting method's relative quality and the estimations of the prediction error of Bicycle Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Bicycle Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 115.9538 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.285 |
| MAPE | Mean absolute percentage error | 0.0417 |
| SAE | Sum of the absolute errors | 17.3864 |
Predictive Modules for Bicycle Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Bicycle Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Bicycle Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Bicycle Therapeutics After-Hype Price Density Analysis
As far as predicting the price of Bicycle Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Bicycle Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Bicycle Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Bicycle Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Bicycle Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Bicycle Therapeutics' historical news coverage. Bicycle Therapeutics' after-hype downside and upside margins for the prediction period are 3.04 and 10.00, respectively. We have considered Bicycle Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Bicycle Therapeutics is slightly risky at this time. Analysis and calculation of next after-hype price of Bicycle Therapeutics is based on 3 months time horizon.
Bicycle Therapeutics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Bicycle Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Bicycle Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Bicycle Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.12 | 3.48 | 0.02 | 0.01 | 9 Events / Month | 5 Events / Month | In about 9 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
6.42 | 6.52 | 0.00 |
|
Bicycle Therapeutics Hype Timeline
Bicycle Therapeutics is currently traded for 6.42. The entity has historical hype elasticity of -0.02, and average elasticity to hype of competition of 0.01. Bicycle is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is currently at -0.12%. %. The volatility of related hype on Bicycle Therapeutics is about 3411.76%, with the expected price after the next announcement by competition of 6.43. About 79.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.74. Some equities with similar Price to Book (P/B) outperform the market in the long run. Bicycle Therapeutics recorded a loss per share of 3.62. The entity had not issued any dividends in recent years. Given the investment horizon of 90 days the next anticipated press release will be in about 9 days. Check out Historical Fundamental Analysis of Bicycle Therapeutics to cross-verify your projections.Bicycle Therapeutics Related Hype Analysis
Having access to credible news sources related to Bicycle Therapeutics' direct competition is more important than ever and may enhance your ability to predict Bicycle Therapeutics' future price movements. Getting to know how Bicycle Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Bicycle Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| RAPT | RAPT Therapeutics | 0.74 | 6 per month | 3.09 | 0.14 | 7.87 | (6.78) | 64.03 | |
| NMRA | Neumora Therapeutics | (0.11) | 7 per month | 0.00 | (0.05) | 9.77 | (7.30) | 33.25 | |
| OMER | Omeros | 0.60 | 7 per month | 4.53 | 0.1 | 12.62 | (7.99) | 87.69 | |
| LXRX | Lexicon Pharmaceuticals | (0.01) | 7 per month | 4.31 | 0.02 | 9.86 | (7.65) | 31.36 | |
| KALV | Kalvista Pharmaceuticals | (0.01) | 10 per month | 3.16 | 0.13 | 8.43 | (5.92) | 25.15 | |
| ADCT | ADC Therapeutics SA | 0.03 | 10 per month | 0.00 | (0.02) | 8.49 | (7.06) | 22.84 | |
| PRTA | Prothena plc | 0.00 | 0 per month | 0.00 | (0.09) | 4.76 | (4.36) | 13.99 | |
| FDMT | 4D Molecular Therapeutics | 0.37 | 9 per month | 0.00 | (0.05) | 7.04 | (9.30) | 28.25 | |
| FULC | Fulcrum Therapeutics | (0.59) | 9 per month | 4.62 | 0.06 | 11.56 | (7.84) | 53.80 | |
| CMPX | Compass Therapeutics | 0.00 | 0 per month | 2.79 | 0.21 | 7.61 | (5.14) | 16.90 |
Other Forecasting Options for Bicycle Therapeutics
For every potential investor in Bicycle, whether a beginner or expert, Bicycle Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Bicycle Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Bicycle. Basic forecasting techniques help filter out the noise by identifying Bicycle Therapeutics' price trends.Bicycle Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Bicycle Therapeutics stock to make a market-neutral strategy. Peer analysis of Bicycle Therapeutics could also be used in its relative valuation, which is a method of valuing Bicycle Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Bicycle Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Bicycle Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Bicycle Therapeutics shares will generate the highest return on investment. By undertsting and applying Bicycle Therapeutics stock market strength indicators, traders can identify Bicycle Therapeutics entry and exit signals to maximize returns.
Bicycle Therapeutics Risk Indicators
The analysis of Bicycle Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Bicycle Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting bicycle stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.92 | |||
| Standard Deviation | 3.82 | |||
| Variance | 14.58 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Bicycle Therapeutics
The number of cover stories for Bicycle Therapeutics depends on current market conditions and Bicycle Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Bicycle Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Bicycle Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Bicycle Therapeutics Short Properties
Bicycle Therapeutics' future price predictability will typically decrease when Bicycle Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Bicycle Therapeutics often depends not only on the future outlook of the potential Bicycle Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Bicycle Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 58.2 M | |
| Cash And Short Term Investments | 879.5 M |
Check out Historical Fundamental Analysis of Bicycle Therapeutics to cross-verify your projections. For information on how to trade Bicycle Stock refer to our How to Trade Bicycle Stock guide.You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Will Biotechnology sector continue expanding? Could Bicycle diversify its offerings? Factors like these will boost the valuation of Bicycle Therapeutics. Projected growth potential of Bicycle fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Bicycle Therapeutics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (3.62) | Revenue Per Share | Quarterly Revenue Growth 3.385 | Return On Assets | Return On Equity |
The market value of Bicycle Therapeutics is measured differently than its book value, which is the value of Bicycle that is recorded on the company's balance sheet. Investors also form their own opinion of Bicycle Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Bicycle Therapeutics' true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Bicycle Therapeutics' market value can be influenced by many factors that don't directly affect Bicycle Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Bicycle Therapeutics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Bicycle Therapeutics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Bicycle Therapeutics' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.